| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 210.31B | 210.86B | 208.30B | 212.38B | 220.13B | 206.49B |
| Gross Profit | 129.55B | 129.23B | 126.34B | 125.70B | 129.31B | 121.56B |
| EBITDA | 19.02B | 20.32B | 16.19B | 16.85B | 18.17B | 21.95B |
| Net Income | 8.54B | 8.80B | 5.84B | 7.42B | 10.20B | 11.04B |
Balance Sheet | ||||||
| Total Assets | 317.11B | 312.46B | 300.69B | 285.59B | 254.18B | 240.21B |
| Cash, Cash Equivalents and Short-Term Investments | 32.01B | 36.21B | 37.40B | 32.28B | 29.57B | 30.96B |
| Total Debt | 137.55B | 130.26B | 119.55B | 111.34B | 84.32B | 73.40B |
| Total Liabilities | 177.37B | 170.80B | 164.50B | 159.15B | 135.13B | 126.98B |
| Stockholders Equity | 139.39B | 141.31B | 135.19B | 125.50B | 118.27B | 112.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.34B | -4.01B | -21.76B | -9.47B | 12.54B |
| Operating Cash Flow | 0.00 | 9.69B | 12.77B | 8.24B | 7.15B | 20.77B |
| Investing Cash Flow | 0.00 | -17.79B | -14.40B | -29.92B | -17.03B | -5.18B |
| Financing Cash Flow | 0.00 | 6.72B | 5.97B | 23.53B | 8.65B | -7.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥45.49B | 18.73 | ― | 4.27% | 6.15% | -25.28% | |
71 Outperform | ¥85.08B | 5.42 | 6.96% | 2.98% | 1.15% | 86.72% | |
65 Neutral | $974.69B | 17.87 | 49.14% | 2.82% | 6.80% | 0.62% | |
63 Neutral | ¥128.44B | 16.01 | ― | 1.54% | 4.78% | 3.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥43.81B | 15.79 | ― | 3.31% | 0.88% | -138.66% | |
41 Neutral | $1.60T | -12.21 | -21.14% | ― | 11.45% | 42.34% |